🌱 The new plant features 60,500 sq-ft of space, including GMP-certified cleanrooms. It aims to enhance support for MedTech and pharmaceutical partners in North America.
💡 Sanner combines local and global resources to deliver innovative solutions in drug delivery and packaging.
Introduction:
The opening of Sanner’s first production facility in Greensboro, North Carolina, represents a significant advancement in the company’s 134-year history, emphasizing localized production to enhance service to MedTech and pharmaceutical partners in North America.
- Germany-based Sanner has inaugurated its first U.S. production facility in Greensboro, NC, marking the expansion of its operations in North America.
- The facility includes a 60,500 square foot area equipped with GMP-certified cleanrooms, advanced technologies for injection molding, and a designed capability for future expansion.
- Sanner aims to bolster its commitment to local production tailored to the unique needs of customers in North America, promoting innovation and sustainable growth.
- The new site is integrated with Gilero, Sanner’s Design Center of Excellence, enhancing local and global manufacturing capabilities, along with regulatory insights.
- This initiative reflects Sanner’s strategy to address the evolving demands of healthcare customers worldwide, providing comprehensive solutions from a single source.
Conclusion:
The establishment of the Greensboro facility is a strategic move for Sanner, reinforcing its dedication to meeting North American market demands with localized production. This development not only promises to enhance customer service and operational efficiencies but also solidifies Sanner’s role as a key player in the global healthcare supply chain. The facility’s design allows for future growth, positioning the company well to adapt to the dynamic healthcare landscape.
